DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography

Information source: Federal University of Juiz de Fora
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cardiopulmonary Bypass Graft

Intervention: epinephrine and levosimendan (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Federal University of Juiz de Fora

Official(s) and/or principal investigator(s):
Marcello F Salgado Filho, Master, Principal Investigator, Affiliation: National Institute of Cardiology/Ministry of Health

Summary

This is a double blind randomization study, assessing hemodynamic response in patients who underwent a cardiopulmonary bypass graft (CABG) with cardiopulmonary bypass (CPB) using intraoperative trasnesophageal echocardiography (TEE) to know what inotropic drug will be batter to improve the heart function. Epinephrine, milrinone, dobutamine and levosimendan will be assessment.

Clinical Details

Official title: Assessment and Hemodynamic Response in CABG After Cardiopulmonary Bypass Using Intraoperative Transesophegeal Echocardiography

Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: Systolic and diastolic heart function

Secondary outcome: Mortality after CABAG

Eligibility

Minimum age: 45 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Sinusal ritmus

- EF > 35%

- Elective CABG surgery

Exclusion Criteria:

- No accept

- Severe valvular regurgitation or stenoses

- Chest pain

- Cardiogenic shock

Locations and Contacts

National Institute of Cardiology / Ministry of Health, Rio de janeiro, RJ 3600-100, Brazil
Additional Information

Starting date: February 2012
Last updated: May 29, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017